U.S. Markets close in 2 hrs 26 mins

What Analysts Recommend for Pfizer and Bristol-Myers Squibb

Margaret Patrick
What Analysts Recommend for Pfizer and Bristol-Myers Squibb

This year, Pfizer (PFE) stock has fallen 0.34% and Bristol-Myers Squibb (BMY) stock has fallen 6.48%. Both companies are focused on strengthening their position in the high-growth oncology and immunology markets. Let's take a closer look at each.